Medical
The robot received FDA breakthrough device designation.
A dated step forward on the record
What the source says
“The robot, which received breakthrough device designation in September 2025, is the first device in a new FDA classification for electromechanical surgical systems”
What it means
The designation was the first step on a path that, on our record, ended with FDA authorization on 10 Nov 2026. That moved Virtuoso Surgical to stage 5, Regulator-cleared or mass market, about fourteen months after September 2025. Stage 5 here means cleared, not widely used. Our record shows no customers or sales for Virtuoso yet. Other robots at stage 5, such as da Vinci 5 and Ion, show quarterly placement counts, so so far Virtuoso has not shown that kind of uptake.
Virtuoso Surgical Robotic System, from Virtuoso Surgical, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Its stage is set by other milestones on its record; this one adds to the history.
Human help: The maker hasn't said whether people help it remotely.
Written with AI from our record of Virtuoso Surgical Robotic System and checked against it: every figure appears in that record.
More on Virtuoso Surgical Robotic System
